Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Prospective evaluation of 68Ga-RM2 PET/MRI and 68Ga-PSMA11 PET/CT in patients with biochemical recurrence of prostate cancer

Lucia Baratto, Heying Duan, NEGIN HATAMI, Akira Toriihara, Hong Song and Andrei Iagaru
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 589;
Lucia Baratto
4Radiology Department, Nuclear Medicine Division Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heying Duan
1Nuclear Medicine and Molecular Imaging Stanford Los Altos CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NEGIN HATAMI
2Radiology Stanford Hospital Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Toriihara
4Radiology Department, Nuclear Medicine Division Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Song
3Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Iagaru
3Stanford University Stanford CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective evaluation of 68Ga-RM2 PET/MRI and 68Ga-PSMA11 PET/CT in patients with biochemical recurrence of prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prospective evaluation of 68Ga-RM2 PET/MRI and 68Ga-PSMA11 PET/CT in patients with biochemical recurrence of prostate cancer
Lucia Baratto, Heying Duan, NEGIN HATAMI, Akira Toriihara, Hong Song, Andrei Iagaru
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 589;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective evaluation of 68Ga-RM2 PET/MRI and 68Ga-PSMA11 PET/CT in patients with biochemical recurrence of prostate cancer
Lucia Baratto, Heying Duan, NEGIN HATAMI, Akira Toriihara, Hong Song, Andrei Iagaru
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 589;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Simultaneous PET/MR reveals significant correlation between the intravoxel incoherent motion parameters and standardized uptake values in nasopharyngeal carcinoma patients
  • Accuracy of 18F-fluoroethyltyrosine PET for detecting high grade glioma recurrence: size matters
Show more Oncology: Clinical Therapy and Diagnosis

Prostate Diagnosis I

  • The contribution of multiparametric pelvic and whole body MR to the interpretation of 18F-fluoromethylcholine (FCH) or 68Ga-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy.
  • PSMA-ligand PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy: matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007
Show more Prostate Diagnosis I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire